Shares of UnitedHealth Group Inc. took a deep dive Tuesday, after the health insurer said it no longer backed its full-year financial outlook, as medical costs continued to rise more than expected.

As expected, Microsoft Build, the company's annual developer conference, featured artificial intelligence at center stage. The company's AI companion, Microsoft Copilot, received several upgrades ...

Goldman Sachs has increased its global oil demand forecast but maintained its price predictions for Brent crude and WTI for the current year, despite current trading values exceeding those ...

Mary Cunningham is a reporter for CBS MoneyWatch. Before joining the business and finance vertical, she worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate ...

The U.S.-China agreement over the weekend to slash outsize reciprocal tariffs during a 90-day pause in their trade war is expected to notably boost America’s projected economic growth this year ...

LYNCHBURG, Va. (WSET) — UPDATE: Lynchburg Police are investigating a Sunday night shooting on Second Street. At approximately 7:23 p.m., the Lynchburg Police Department received a report of ...

GT-008 is a first-in-class, glycan-dependent monoclonal antibody targeting CD24, a surface protein implicated in tumor progression. By recognizing a tumor-associated O-glycoform of CD24—limited in ...

In the popular Apple TV+ show Ted Lasso, the titular character plays a relentlessly positive soccer coach whose care and kindness inspires his ragtag team to reach new heights. And, in fact, past ...

The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

Among the changes mentioned in yesterday's Nintendo Switch 2 presentation was a note that the new console doesn't just support MicroSD Express cards for augmenting the device's 256GB of internal ...

The biotech set aside a further 10% of its IPO haul for a planned trial of anti-CD24 antibody IMM47. ImmuneOnco revealed (PDF) a shift in its plan after the Hong Kong stock market closed Tuesday.

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery ...